Table 1 (A) Baseline characteristics TURP patients, (B) Baseline characteristics HoLEP patients.

From: Propensity score-matched evaluation of palliative transurethral resection and holmium laser enucleation of the prostate for bladder outlet obstruction in patients with prostate cancer

A

Characteristics

 

TURP (n = 42)

pTURP (n = 42)

p value

Age (yr)

   Median

71

71

0.871

   IQR

69–77

69–77

 

IPSS

   Median

25

25

0.528

   IQR

21–28

21–29

 

QoL

   Median

4

4

0.524

   IQR

4–4.5

4–5

 

PV (cc)

   Median

41

41

0.731

   IQR

35–45

40–44

 

Total PSA (ng/ml)

   Median

3.5

15.6

0.008

   IQR

1.6–5.8

3.6–27.7

 

PSA density (ng/mL/cc)

   Median

0.06

0.39

0.01

   IQR

0.04–0.14

0.09–0.69

 

Qmax (ml/s)

   Median

9

11

0.181

   IQR

7–10.3

9–13

 

PVR (ml)

   Median

182

155

0.325

   IQR

164–196

91–310

 

Hb (g/dl)

   Median

14.9

14.1

0.541

   IQR

13.3–15.7

13.4–14.9

 

ASA (%)

   ≥3 vs < 3

45.2%

47.6%

0.827

   IDC (%) n

47.6% (20)

52.3% (22)

0.586

Gleason score, n (%)

   ≤6

–

1 (2.4%)

 

   7

–

1 (2.4%)

 

   8–10

–

40 (95.2%)

 

B

Characteristics

 

HoLEP (n = 48)

pHoLEP (n = 48)

p value

Age (yr)

   Median

76

76

0.78

   IQR

73–79

72–80

 

IPSS

   Median

24

24

0.743

   IQR

20–27

22–26

 

QoL

   Median

4

4

0.362

   IQR

3.5–4.3

4–4

 

PV (cc)

   Median

80

80

0.782

   IQR

70–105

63–100

 

Total PSA (ng/ml)

   Median

8.6

15.2

0.178

   IQR

5.7–18.7

13.2–18.9

 

PSA density (ng/mL/cc)

   Median

0.11

0.19

0.215

   IQR

0.07–0.23

0.17–0.24

 

Qmax (ml/s)

   Median

10

8

0.576

   IQR

7.5–14

8.0–8.8

 

PVR (ml)

   Median

80

101

0.522

   IQR

4–162

64–126

 

Hb (g/dl)

   Median

14.7

14.2

0.454

   IQR

14.2–15.9

13.7–14.7

 

ASA (%)

   ≥3 vs < 3

54.2%

50.0%

0.838

   IDC (%) n

37.5% (18)

45.8% (22)

0.535

Gleason score, n (%)

   ≤6

–

2 (4.2%)

 

   7

–

16 (33.3%)

 

   8–10

–

30 (62.5%)

 
  1. IQR interquartile range, IPSS International Prostate Symptom Index, QoL quality of life, PV prostate volume, PSA prostate-specific-antigen, Qmax peak urinary flow rate, PVR postvoid residual urine, Hb haemoglobin, ASA American Society of Anaesthesiologists, IDC indwelling urinary catheter.
  2. Bold values indicate statistically significant p values (p < 0.05).
Back to article page